![Philippe Wiesel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Wiesel
Hoofd Techniek/Wetenschap/O&O bij
AGOMAB THERAPEUTICS NV
Vermogen: - $ op 31-07-2026
Profiel
Philippe Wiesel is the founder of Genexion SA. Currently, Dr. Wiesel is Chief Medical Officer & Executive Vice President at Calliditas Therapeutics Suisse SA since 2010 and Chief Medical Officer at AgomAb Therapeutics NV since 2021.
Formerly, Dr. Wiesel was Medical Director at EMD Serono, Inc., Serono SA, and Serono International SA, and Clinical Development Advisor at Funxional Therapeutics Ltd. Dr. Wiesel earned a doctorate from the University of Lausanne in 1993.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Philippe Wiesel
| Bedrijven | Functie | Begin |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Hoofd Techniek/Wetenschap/O&O | 26-05-2011 |
Eerdere bekende functies van Philippe Wiesel
| Bedrijven | Functie | Einde |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Hoofd Techniek/Wetenschap/O&O | - |
Serono International SA | Hoofd Techniek/Wetenschap/O&O | - |
Genexion SA | Oprichter | - |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Hoofd Techniek/Wetenschap/O&O | - |
Funxional Therapeutics Ltd.
 Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Corporate Officer/Principal | - |
Opleiding van Philippe Wiesel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
53
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Health Technology |
Serono International SA | |
Genexion SA | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
